Science Explorer Back to mapMap
Discussion
Researcher · Bayer (Germany) · Germany

Philip Lienau

Philip Lienau publishes mostly in Molecular Biology, Oncology and Cell Biology, on topics such as Cancer-related Molecular Pathways, Microtubule and mitosis dynamics and PARP inhibition in cancer therapy.

ORCID 0000-0002-6048-4559 OpenAlex
World rank
#476,107
of 7,710,434 ranked researchers
Rank in Germany
#23,397
of 364,343
Works
119
Citations
2.4k
Citations per work
20.4
h-index
26
i10-index 37Top 20% in Molecular Biology
Philip Lienau

What does Philip Lienau research?

Philip Lienau's work is mostly in Biochemistry, Genetics and Molecular Biology (48%), Medicine (25%), Chemistry (5%).

Life Sciences: 57 works · 48.2% of their workBiochemistry, Genetics and Molecular Biology: 57 works · 48.2% of their workMolecular Biology: 43 works · 36.2% of their workCell Biology: 10 works · 8.0% of their workCancer Research: 5 works · 4.0% of their workHealth Sciences: 29 works · 24.7% of their workMedicine: 29 works · 24.7% of their workOncology: 23 works · 19.0% of their workPulmonary and Respiratory Medicine: 7 works · 5.7% of their workEverything else: 26 works · 21.9% of their workPhysical Sciences: 6 works · 5.2% of their workChemistry: 6 works · 5.2% of their workOrganic Chemistry: 6 works · 5.2% of their workTHEIR WORKPhilip Lienau119works
Life Sciences48%Physical Sciences5%Health Sciences25%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology5748.2%
    1. Medicine2924.7%
  3. Everything else2621.9%
    1. Chemistry65.2%
  1. 1Molecular Biology36% of their works
  2. 2Oncology19% of their works
  3. 3Cell Biology8% of their works
  4. 4Pulmonary and Respiratory Medicine6% of their works
  5. 5Organic Chemistry5% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Philip Lienau's research?

The keywords of their largest research topics: Cancer Therapy, Cell Cycle, p53, Homologous Recombination, Cell Division, Microtubules, BRCA Mutation and Breast Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Therapy323 topics
  2. Cell Cycle171 topic
  3. p53171 topic
  4. Homologous Recombination112 topics
  5. Cell Division91 topic
  6. Microtubules91 topic
  7. BRCA Mutation61 topic
  8. Breast Cancer61 topic
  9. CDK4/6 Inhibitors61 topic
  10. PARP Inhibitors61 topic
  11. BET Bromodomains51 topic
  12. Cyclic Nucleotide Phosphodiesterases51 topic
  13. DNA51 topic
  14. DNA Damage51 topic
  15. PROTACs51 topic
  16. Repair51 topic
  17. Topoisomerases51 topic
  18. cAMP Signaling51 topic

Where does Philip Lienau work?

Philip Lienau's main affiliation in the publication record is Bayer (Germany), Germany.

How many publications and citations does Philip Lienau have?

OpenAlex counts 119 works and 2,432 citations for Philip Lienau, an h-index of 26, ranking #476,107 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Philip Lienau. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.